Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study

Genetic liability to schizophrenia is negatively associated with educational attainment in UK Biobank

(2019) Valentina Escott-Price et al.   MOLECULAR PSYCHIATRY

The Proposal to Lower P Value Thresholds to .005

(2018) John P. A. Ioannidis   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression

(2018) Naomi R. Wray et al.   NATURE GENETICS

Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence

(2018) Jeanne E. Savage et al.   NATURE GENETICS

Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals

(2018) James J. Lee et al.   NATURE GENETICS

Predicting work outcome in patients with schizophrenia: Influence of IQ decline

(2018) Chika Sumiyoshi et al.   SCHIZOPHRENIA RESEARCH

Validation of an algorithm-based definition of treatment resistance in patients with schizophrenia

(2018) Olesya Ajnakina et al.   SCHIZOPHRENIA RESEARCH

Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis

(2018) Jian-Ping Zhang et al.   AMERICAN JOURNAL OF PSYCHIATRY

Effect of Damaging Rare Mutations in Synapse-Related Gene Sets on Response to Short-term Antipsychotic Medication in Chinese Patients With Schizophrenia

(2018) Qiang Wang et al.   JAMA Psychiatry

The Swedish cause of death register

(2017) Hannah Louise Brooke et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia

(2017) Theresa Wimberley et al.   SCHIZOPHRENIA BULLETIN

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia

(2017) Jari Tiihonen et al.   JAMA Psychiatry

Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia

(2017)   Molecular Autism

Shared genetic aetiology between cognitive functions and physical and mental health in UK Biobank (N=112 151) and 24 GWAS consortia

(2016) S P Hagenaars et al.   MOLECULAR PSYCHIATRY

Analysis of protein-coding genetic variation in 60,706 humans

(2016) Monkol Lek et al.   NATURE

Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia

(2016) Giulio Genovese et al.   NATURE NEUROSCIENCE

Profiling cognitive impairment in treatment-resistant schizophrenia patients

(2016) Dorota Frydecka et al.   PSYCHIATRY RESEARCH

Common alleles contribute to schizophrenia in CNV carriers

(2015) K E Tansey et al.   MOLECULAR PSYCHIATRY

Increased rare duplication burden genomewide in patients with treatment-resistant schizophrenia

(2015) A. K. Martin et al.   PSYCHOLOGICAL MEDICINE

Evidence of Common Genetic Overlap Between Schizophrenia and Cognition

(2015) Leon Hubbard et al.   SCHIZOPHRENIA BULLETIN

The effect of lifetime adversities on resistance to antipsychotic treatment in schizophrenia patients

(2015) Ahmed N. Hassan et al.   SCHIZOPHRENIA RESEARCH

Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients

(2014) J Frank et al.   MOLECULAR PSYCHIATRY

Copy number variation in schizophrenia in Sweden

(2014) J P Szatkiewicz et al.   MOLECULAR PSYCHIATRY

A polygenic burden of rare disruptive mutations in schizophrenia

(2014) Shaun M. Purcell et al.   NATURE

Biological insights from 108 schizophrenia-associated genetic loci

(2014)   NATURE

The social and economic burden of treatment-resistant schizophrenia

(2013) James L. Kennedy et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis

(2013)   LANCET

Genome-wide association analysis identifies 13 new risk loci for schizophrenia

(2013) Stephan Ripke et al.   NATURE GENETICS

Prediction of acute clinical response following a first episode of non affective psychosis: Results of a cohort of 375 patients from the Spanish PAFIP study

(2013) Benedicto Crespo-Facorro et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses

(2013) Andrea de Bartolomeis et al.   PSYCHIATRY RESEARCH

Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case–control sample

(2012) E K Green et al.   MOLECULAR PSYCHIATRY

Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs

(2012) S Hong Lee et al.   NATURE GENETICS

External review and validation of the Swedish national inpatient register

(2011) Jonas F Ludvigsson et al.   BMC PUBLIC HEALTH

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

(2011) Thomas RE Barnes et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Treatment resistant schizophrenia and response to antipsychotics: A review

(2011) Takefumi Suzuki et al.   SCHIZOPHRENIA RESEARCH

IQ as a predictor of functional outcome in schizophrenia: A longitudinal, four-year study of first-episode psychosis

(2008) Verity C. Leeson et al.   SCHIZOPHRENIA RESEARCH